Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 13C-Pyruvate MRS in Malignant Brain Tumors
NCT03565367Phase 1Completed
- Start
- Nov 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [1-13C]pyruvate in malignant central nervous system neoplasm. Started Nov 2018; status: completed.
02
Drugs
[1-13C]pyruvate
03
Conditions
malignant central nervous system neoplasm
Beyond the preview
Go deeper on NCT03565367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565367.